CAS: 104901-43-1; Methyl 3-Bromo-4-Methylbenzoate

该化合物是一种有机化合物,其特点是芳香结构,包括甲基酯功能组和苯环上的溴替代物;三点方位的溴原子和四点方位的甲基组,其独特的反应和物理特性是独特的;该化合物一般是无色的黄色液体或固体,视温度和纯度而定;在乙醇和二氯甲烷等有机溶剂中可溶解,但由于其缺水芳烃结构,其水溶性有限.

结构式图片

相似化合物

7697-26-9 36276-24-1 68120-35-4

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

4-methyl-benzoic acid methyl ester methanol 3-bromo-4-methylbenzoic acid dimethyl sulfate2-(3-bromo-4-bromomethylbenzyloxy)tetrahydropyran 3-bromo-4-(bromomethyl)benzoic acid methyl ester [3-bromo-4-(bromomethyl)phenyl]methanol methyl 4-methyl-3-methoxybenzoate

合成工艺路线路线简述

    对甲基苯甲酸甲酯置于三氯化铝,溴体系中,用46%的收率获得3-溴-4-甲基苯甲酸甲酯
    参考文献:(C5Me5)Rh(Pme3)(R)H中烷烃和芳烃碳氢键活化的机理和热力学
    标题:(C5Me5)Rh(Pme3)(R)H中烷烃和芳烃碳氢键活化的机理和热力学
    摘要:使用整体激活参数反应生成C 6/h 6/ 和 (C 5/me 5/)Rh(Pme 3/)(C 6/d 5/)D Delta H +/-30.5 +/-0.8 Kcal/mol 和 ..Delta..S +/-14.9+/-2.5 Eu.烷基和芳基氢化物复合物也可以通过在烷烃存在下从 (C 5/me 5/)Rh(Pme 3/)H 2/ 光化学挤出 H 2/ 产生或芳烃溶剂.在竞争实验中,苯对环戊烷的选择性为 5.4:1,在-35 0/c 时表现出.在-45 0/c 的甲苯溶剂中辐照产生的产物中,观测到甲苯的所有可能 Ch 键的活化增加了 57% » 间位,36% 对位,7% 邻位和 <1% 苄基.苯和甲苯,间二甲苯,邻二甲苯或对二甲苯的活化之间的热力学控制竞争显示出对苯的偏好为
    Doi:10.1021/ja00318A018

    专利信息


    专利号:US-2024400552-A1
    优先权日:2016-11-11
    标题 :Heterocyclic modulators of lipid synthesis
    发明人:BUCKLEY DOUGLAS I; DUKE GREGORY; WAGMAN ALLAN S; EVANCHIK MARC; MCDOWELL ROBERT S
    权利人:SAGIMET BIOSCIENCES INC
    摘要:Compounds that are fatty acid synthesis modulators are provided. The compounds may be used to treat disorders characterized by dysregulation of the fatty acid synthase function by modulating the function and/or the fatty acid synthase pathway. Methods are provided for treating such disorders including viral infections, such as hepatitis C infection, cancer and metabolic disorders, such as non-alcoholic steatohepatitis (NASH).

    专利号:US-11622968-B2
    优先权日:2011-03-08
    标 题:Heterocyclic modulators of lipid synthesis
    发明人:BUCKLEY DOUGLAS; DUKE GREGORY; WAGMAN ALLAN S; EVANCHIK MARC; MCDOWELL ROBERT S
    权利人:SAGIMET BIOSCIENCES INC
    摘要:Compounds that are fatty acid synthesis modulators are provided. The compounds may be used to treat disorders characterized by disregulation of the fatty acid synthase function by modulating the function and/or the fatty acid synthase pathway. Methods are provided for treating such disorders including viral infections, such as hepatitis C infection, cancer and metabolic disorders, such as non-alcoholic steatohepatitis (NASH).

    专利号:US-11034690-B2
    优先权日:2016-11-11
    标 题:Heterocyclic modulators of lipid synthesis
    发明人:BUCKLEY DOUGLAS I; DUKE GREGORY; WAGMAN ALLAN S; EVANCHIK MARC; MCDOWELL ROBERT S
    权利人:SAGIMET BIOSCIENCES INC; SAGINIET BIOSCIENCES INC
    摘要:Compounds that are fatty acid synthesis modulators are provided. The compounds may be used to treat disorders characterized by disregulation of the fatty acid synthase function by modulating the function and/or the fatty acid synthase pathway. Methods are provided for treating such disorders including viral infections, such as hepatitis C infection, cancer and metabolic disorders, such as non-alcoholic steatohepatitis (NASH).

    专利号:US-9809591-B2
    优先权日:2011-03-08
    标题 :Heterocyclic modulators of lipid synthesis
    发明人:OSLOB JOHAN D; MCDOWELL ROBERT S; JOHNSON RUSSELL; YANG HANBIAO; EVANCHIK MARC; ZAHARIA CRISTIANA A; CAI HAIYING; HU LILY W
    权利人:3-V BIOSCIENCES INC
    摘要:Compounds that are fatty acid synthesis modulators are provided. The compounds may be used to treat disorders characterized by disregulation of the fatty acid synthase function by modulating the function and/or the fatty acid synthase pathway. Methods are provided for treating such disorders including viral infections, such as hepatitis C infection, cancer and metabolic disorders.

    专利号:US-12227528-B2
    优先权日:2017-11-09
    标 题:Glucose-sensitive albumin-binding derivatives
    发明人:KRUSE THOMAS; KOFOD-HANSEN MIKAEL; MUENZEL MARTIN WERNER BORCHSENIUS; THOEGERSEN HENNING; SAUERBERG PER; EWALD JAKOB; BEHRENS CARSTEN; HOEG-JENSEN THOMAS; BALSANEK VOJTECH; DROBNAKOVA ZUZANA; DROZ LADISLAV; HAVRANEK MIROSLAV; KOTEK VLADISLAV; STENGL MILAN; SNAJDR IVAN; DRUSANOVA HANA
    权利人:NOVO NORDISK AS
    摘要:This invention relates to glucose-sensitive albumin-binding diboron conjugates. More particularly the invention provides novel diboron compounds, and in particular diboronate or diboroxole compounds, useful as intermediate compounds for the synthesis of diboron conjugates.

    专利号:US-2019308969-A1
    优先权日:2016-11-11
    标 题 :Heterocyclic modulators of lipid synthesis
    阜新清稷升科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.qjsfb.com
    企业联系电话:陈佳|运营副总 13588048971👤
    📞阜新清稷升科技有限公司 ⚠️参考联系方式
    联系人:陈佳|运营副总
    电话:陈佳|运营副总 13588048971
    手机:13588048971
    传真:0418-8189431
    邮箱:sales@bomanbiochem.com
    通信地址: 阜新市阜蒙县氟化工园区
    邮编: 123000
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:阜新市阜蒙县氟化工园区
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    常州鸿达新材料科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.globalhongdachem.com
    企业联系电话:18961205066👤
    📞常州鸿达新材料科技有限公司 ⚠️参考联系方式
    联系人:周先生
    电话:18961205066
    手机:18961205066
    传真:QQ:172235065
    邮箱:sales@globalhongdachem.com
    通信地址: 江苏省常州市武进区湖塘镇人民西路2-3
    邮编:
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:江苏省常州市武进区湖塘镇人民西路2-3
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    参考文献:10.1055/s-0037-1610714
    摘要:Steven A. Micelle-Mediated Chemistry in Water for the Synthesis of Drug Candidates. Synthesis. 2019 May 21;51(13):2632–47. doi: 10.1055/s-0037-1610714.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知